These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33554133)

  • 21. 'Snakes & Ladders': factors influencing access to appropriate care for children and young people with suspected juvenile idiopathic arthritis - a qualitative study.
    Rapley T; May C; Smith N; Foster HE
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):43. PubMed ID: 33757545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The childhood arthritis radiographic score of the hip: the proposal cut-off value using cluster analysis.
    Ferjani HL; Dhia SB; Nessib DB; Dghaies A; Kaffel D; Maatallah K; Hamdi W
    Clin Rheumatol; 2024 Jan; 43(1):465-472. PubMed ID: 37635192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry.
    Shiff NJ; Shrader P; Correll CK; Dennos A; Phillips T; Beukelman T;
    Rheumatology (Oxford); 2023 Feb; 62(2):804-814. PubMed ID: 35703945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physician assessment of disease activity in JIA subtypes. Analysis of data extracted from electronic medical records.
    Miller ML; Ruprecht J; Wang D; Zhou Y; Lales G; McKenna S; Klein-Gitelman M
    Pediatr Rheumatol Online J; 2011 Apr; 9(1):9. PubMed ID: 21492466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study.
    Kearsley-Fleet L; Heaf E; Davies R; Baildam E; Beresford MW; Foster HE; Southwood TR; Thomson W; Hyrich KL;
    Lancet Rheumatol; 2020 Apr; 2(4):e217-e226. PubMed ID: 32280951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study.
    Oen K; Tucker L; Huber AM; Miettunen P; Scuccimarri R; Campillo S; Cabral DA; Feldman BM; Tse S; Chédeville G; Spiegel L; Schneider R; Lang B; Ellsworth J; Ramsey S; Dancey P; Silverman E; Chetaille AL; Cameron B; Johnson N; Dorval J; Petty RE; Duffy KW; Boire G; Haddad E; Houghton K; Saint-Cyr C; Turvey SE; Benseler S; Cheang M; Yeung RS; Duffy CM
    Arthritis Rheum; 2009 Aug; 61(8):1077-86. PubMed ID: 19644903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of temporomandibular disorder in children and adolescents with juvenile idiopathic arthritis - a Norwegian cross- sectional multicentre study.
    Fischer J; Skeie MS; Rosendahl K; Tylleskär K; Lie S; Shi XQ; Gil EG; Cetrelli L; Halbig J; von Wangenheim Marti L; Rygg M; Frid P; Stoustrup P; Rosèn A
    BMC Oral Health; 2020 Oct; 20(1):282. PubMed ID: 33050890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study.
    Guzman J; Gómez-Ramírez O; Jurencak R; Shiff NJ; Berard RA; Duffy CM; Oen K; Petty RE; Benseler SM; Brant R; Tucker LB
    J Rheumatol; 2014 Nov; 41(11):2260-9. PubMed ID: 25225279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort study.
    Milatz F; Hansmann S; Klotsche J; Niewerth M; Kallinich T; Dressler F; Haas JP; Berendes R; Horneff G; Hufnagel M; Weller-Heinemann F; Windschall D; Trauzeddel R; Klaas M; Girschick H; Oommen PT; Foeldvari I; Cantez SM; Jansson AF; Hartmann M; Peitz-Kornbrust J; Minden K
    Pediatr Rheumatol Online J; 2024 Mar; 22(1):39. PubMed ID: 38509613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatigue in young adults with juvenile idiopathic arthritis 18 years after disease onset: data from the prospective Nordic JIA cohort.
    Arnstad ED; Glerup M; Rypdal V; Peltoniemi S; Fasth A; Nielsen S; Zak M; Aalto K; Berntson L; Nordal E; Herlin T; Romundstad PR; Rygg M;
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):33. PubMed ID: 33736650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of PROMIS® to screen for depression in children with arthritis.
    Yan Y; Rychlik KL; Rosenman MB; Miller ML
    Pediatr Rheumatol Online J; 2020 Nov; 18(1):92. PubMed ID: 33228749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study.
    Hyrich KL; Lal SD; Foster HE; Thornton J; Adib N; Baildam E; Gardner-Medwin J; Wedderburn LR; Chieng A; Davidson J; Thomson W
    Rheumatology (Oxford); 2010 Jan; 49(1):116-22. PubMed ID: 19926670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
    Shepherd J; Cooper K; Harris P; Picot J; Rose M
    Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CAPTURE-JIA: a consensus-derived core dataset to improve clinical care for children and young people with juvenile idiopathic arthritis.
    McErlane F; Armitt G; Cobb J; Bailey K; Cleary G; Douglas S; Lunt L; Rashid A; Sampath S; Shoop-Worrall S; Smith N; Foster H; Thomson W
    Rheumatology (Oxford); 2020 Jan; 59(1):137-145. PubMed ID: 31243450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
    Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time to diagnosis in juvenile idiopathic arthritis: a french perspective.
    Aoust L; Rossi-Semerano L; Koné-Paut I; Dusser P
    Orphanet J Rare Dis; 2017 Feb; 12(1):43. PubMed ID: 28241879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Validated Clinical and Patient Reported Disease Outcome Measures in Juvenile Idiopathic Arthritis.
    Balay-Dustrude E; Shenoi S
    Open Access Rheumatol; 2023; 15():189-206. PubMed ID: 37841510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'The current mental health status of children and young people with JIA, and their wider family': a charity partner collaboration survey.
    Livermore P; Ainsworth S; Beesley R; Douglas S; Earle E; Wilson D; Woolley L; Clinch J
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):111. PubMed ID: 37798784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.
    Viswanath V; Myles A; Dayal R; Aggarwal A
    J Rheumatol; 2011 Nov; 38(11):2482-7. PubMed ID: 21885500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care.
    Barber CEH; Twilt M; Pham T; Currie GR; Benseler S; Yeung RSM; Batthish M; Blanchette N; Guzman J; Lang B; LeBlanc C; Levy DM; O'Brien C; Schmeling H; Soon G; Spiegel L; Whitney K; Marshall DA
    Arthritis Res Ther; 2020 Mar; 22(1):53. PubMed ID: 32192528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.